Biotech | March 21, 2022
Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
The facility will produce 150 million vaccine doses per year
The facility will produce 150 million vaccine doses per year
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
This is the ninth Covid-19 vaccine approved in India
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The vaccines are currently only authorised for emergency use in the country
However, these won’t be available at the nearest chemist store soon
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Subscribe To Our Newsletter & Stay Updated
